z-logo
open-access-imgOpen Access
Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis
Author(s) -
Akiharu Kimura,
Kenichi Ogata,
Bolag Altan,
Takehiko Yokobori,
Erito Mochiki,
Mitsuhiro Yanai,
Norimichi Kogure,
Toru Yanoma,
Masaki Suzuki,
Tuya Bai,
Hiroyuki Kuwano
Publication year - 2017
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v23.i42.7541
Subject(s) - chemotherapy , medicine , immunohistochemistry , heat shock protein , metastasis , hsp70 , cancer , cancer cell , apoptosis , pathology , cancer research , gastroenterology , oncology , biology , biochemistry , gene
To investigate the significance of heat shock protein 110 (HSP110) in gastric cancer (GC) patients with peritoneal metastasis undergoing hyperthermo-chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here